Patent, Intellectual Property and Priority

Nucleotide Sequence Data Related to Patent Applications

Nucleotide sequence data related to patent applications are transferred from Japan Patent Office (JPO) and Korean Intellectual Property Office (KIPO)^* to DDBJ.

* The procedure to transfer the sequence data from KIPO to DDBJ has been established since February 2008.

DDBJ services also include the nucleotide data transferred from European Patent Office (EPO) and United States Patent and Trademark Office (USPTO).

Notice: Submission of Patent Related Sequences

As the sequence data released by DDBJ is open to the public, DDBJ takes no responsibility for any property and priority issues of the released data.

Therefore, if one is to submit patent related sequence data to a patent office and DDBJ, one should consult the patent office and DDBJ ( ) about the release date from DDBJ, before submission.

Patent Priority and Other Priority

Patent Priority

If you submit nucleotide sequence data to DDBJ, you get NO patent priority for the data.
DDBJ takes no responsibility for any property and priority issues for patenting.

If necessary, you should consult the patent office, before submitting your data to DDBJ.

Other Priority

Submitting your nucleotide sequence data to DDBJ, EMBL Bank or GenBank does not necessarily guarantee the priority of the data as shown in the following examples.

• Nomenclature of new species: See also Organism Qualifier
• Nomenclature of gene and protein: See also Gene nomenclature at DDBJ